➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Boehringer Ingelheim
McKinsey
Colorcon
Medtronic

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

VFEND Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Vfend patents expire, and when can generic versions of Vfend launch?

Vfend is a drug marketed by Pf Prism Cv and is included in three NDAs.

The generic ingredient in VFEND is voriconazole. There are fourteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the voriconazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vfend

A generic version of VFEND was approved as voriconazole by MYLAN PHARMS INC on April 22nd, 2010.

  Try Before You Buy

Paragraph IV (Patent) Challenges for VFEND
Tradename Dosage Ingredient NDA Submissiondate
VFEND FOR SUSPENSION;ORAL voriconazole 021630 2010-10-08
VFEND INJECTABLE;INTRAVENOUS voriconazole 021267 2008-09-12
VFEND TABLET;ORAL voriconazole 021266 2008-04-14

US Patents and Regulatory Information for VFEND

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pf Prism Cv VFEND voriconazole FOR SUSPENSION;ORAL 021630-001 Dec 19, 2003 AB RX Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole TABLET;ORAL 021266-002 May 24, 2002 AB RX Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole INJECTABLE;INTRAVENOUS 021267-001 May 24, 2002 AP RX Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole TABLET;ORAL 021266-001 May 24, 2002 AB RX Yes No   Try Before You Buy   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VFEND

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv VFEND voriconazole FOR SUSPENSION;ORAL 021630-001 Dec 19, 2003   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole TABLET;ORAL 021266-001 May 24, 2002   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole INJECTABLE;INTRAVENOUS 021267-001 May 24, 2002   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole INJECTABLE;INTRAVENOUS 021267-001 May 24, 2002   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole FOR SUSPENSION;ORAL 021630-001 Dec 19, 2003   Try Before You Buy   Try Before You Buy
Pf Prism Cv VFEND voriconazole INJECTABLE;INTRAVENOUS 021267-001 May 24, 2002   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for VFEND

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0440372 C300100 Netherlands   Try Before You Buy PRODUCT NAME: VORICONAZOLUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/02/212/001-025 20020319
0440372 02C0030 France   Try Before You Buy PRODUCT NAME: VORICONAZOLE; NAT. REGISTRATION NO/DATE: EU/1/02/212/001-025 20020319; FIRST REGISTRATION: EU/1/02/212/001-25 20020319
1001813 PA2003005 Lithuania   Try Before You Buy PRODUCT NAME: VORICONAZOLIS; REGISTRATION NO/DATE: 02/7890/8 20021002
0440372 90960 Luxembourg   Try Before You Buy
0440372 SPC/GB02/031 United Kingdom   Try Before You Buy PRODUCT NAME: VORICONAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/02/212/001-025 20020319
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.